Cambridge Cognition, a Division of CeNeS Pharmaceuticals, Plans AIM Listing
10 sept. 2001 03h23 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, Netherlands, Sept. 10, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced plans to float its cognition subsidiary, Cambridge Cognition, on AIM later in the...
CeNeS Launches Novel Pain Drug and Establishes Specialized Hospital Sales Force
06 sept. 2001 02h28 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, UK, Sept. 5, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that it has launched Xefo, a novel analgesic for the treatment of post-operative pain, in the...